Notable companies
The most notable companies in this group are NVIDIA Corp (NASDAQ:NVDA), Alphabet (NASDAQ:GOOGL), Eli Lilly & Co (NYSE:LLY), ABBVIE (NYSE:ABBV), AstraZeneca PLC (NASDAQ:AZN), ZOETIS (NYSE:ZTS), Regeneron Pharmaceuticals (NASDAQ:REGN), DuPont de Nemours (NYSE:DD), Biogen (NASDAQ:BIIB), Exact Sciences Corp (NASDAQ:EXAS).
Industry description
The investment seeks long term capital appreciation.
The fund invests mainly in common stocks (growth or value stocks or both) of companies worldwide of any size with a focus on “biology revolution” companies. From time to time, the fund may invest a significant portion of its assets in companies in one or more related industries or sectors, including the health care, consumer discretionary, consumer staples, biotechnology and materials sectors. The fund is non-diversified.
Market Cap
The average market capitalization across the Putnam BioRevolution ETF ETF is 189.51B. The market cap for tickers in the group ranges from 706.76M to 3.24T. NVDA holds the highest valuation in this group at 3.24T. The lowest valued company is RCKT at 706.76M.
High and low price notable news
The average weekly price growth across all stocks in the Putnam BioRevolution ETF ETF was 9%. For the same ETF, the average monthly price growth was 35%, and the average quarterly price growth was 79%. NVZMY experienced the highest price growth at 5%, while DAR experienced the biggest fall at -11%.
Volume
The average weekly volume growth across all stocks in the Putnam BioRevolution ETF ETF was -65%. For the same stocks of the ETF, the average monthly volume growth was -64% and the average quarterly volume growth was -63%
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Valuation Rating: 60
P/E Growth Rating: 69
Price Growth Rating: 56
SMR Rating: 68
Profit Risk Rating: 63
Seasonality Score: 14 (-100 ... +100)